Home > Products > BCMA & CD3
> Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (BsIgG)
Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (BsIgG) (CAT#: KN-0422-LN15)
Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (BsIgG) is designed to be expressed as four chains with Fc mutations to form heterodimers. It has the general size and structure of a conventional IgG. The Fc region also engineered to decrease Fc-mediated functions, but remains the half-life. This BsAb can retarget T cells to tumor cells. It is designed for the research of Multiple myeloma (MM) therapy.
There are currently no customer reviews or questions for Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (BsIgG) (KN-0422-LN15). Click the button below to contact us or submit your feedback about this product.